Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cutaneous Sclerosis”

80 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 80 results

Testing effectiveness (Phase 2)Study completedNCT03041025
What this trial is testing

Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Scleroderma, Systemic
GlaxoSmithKline 35
Testing effectiveness (Phase 2)Looking for participantsNCT07473154
What this trial is testing

Controlling Hyperactive Immunity With Long-lived Lymphocytes

Who this might be right for
Diffuse Cutaneous Systemic SclerosisRheumatoid Arthritis (RA)Systemic Sclerosis (SSc)+1 more
Quell Therapeutics Limited 16
Testing effectiveness (Phase 2)Study completedNCT04137224
What this trial is testing

Safety and Pharmacokinetics of IgPro20 and IgPro10 in Adults With Systemic Sclerosis (SSc)

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
CSL Behring 27
Post-approval studies (Phase 4)Study completedNCT04464434
What this trial is testing

Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Systemic SclerosisSystemic Scleroses, DiffuseScleroderma+5 more
UMC Utrecht 60
Not applicableLooking for participantsNCT05747937
What this trial is testing

Longitudinal Assessment of Autonomic and Sensory Nervous System in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Istituti Clinici Scientifici Maugeri SpA 100
Not applicableLooking for participantsNCT05273138
What this trial is testing

Analysis of Dermal Fibroblasts and Immune Cells During Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
University Hospital, Lille 40
Early research (Phase 1)Looking for participantsNCT06925542
What this trial is testing

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Who this might be right for
SLE (Systemic Lupus)Lupus Erythematosus, SystemicLupus Nephritis+4 more
CRISPR Therapeutics 80
Testing effectiveness (Phase 2)Study completedNCT00479934
What this trial is testing

Efficacy and Safety of Imatinib in Scleroderma

Who this might be right for
Scleroderma, LocalizedScleroderma, Systemic
University Hospital, Bordeaux 28
Early research (Phase 1)Study completedNCT00433186
What this trial is testing

Mycophenolate Mofetil in Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Boston University 30
Early research (Phase 1)Study completedNCT00656825
What this trial is testing

Tolerability and Bioavailability of the P144 Peptide Inhibitor of TGF-β1 After Topical Administration in Healthy Volunteers

Who this might be right for
Healthy
ISDIN 36
Not applicableStudy completedNCT02339441
What this trial is testing

Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Early Diffuse Cutaneous Systemic Sclerosis
University of Manchester 320
Testing effectiveness (Phase 2)Study completedNCT02503644
What this trial is testing

Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Scleroderma, DiffuseDiffuse Cutaneous Systemic Sclerosis
Inventiva Pharma 145
Testing effectiveness (Phase 2)Study completedNCT01651143
What this trial is testing

Proof of Biological Activity of SAR100842 in Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Sanofi 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT02682511
What this trial is testing

Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension

Who this might be right for
Scleroderma, DiffuseScleroderma, SystemicScleroderma, Limited+5 more
Cumberland Pharmaceuticals 34
Early research (Phase 1)Study completedNCT03817424
What this trial is testing

Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis

Who this might be right for
Systemic Lupus ErythematosusCutaneous Lupus ErythematosusSjogren's Syndrome+3 more
Amgen 31
Not applicableLooking for participantsNCT00001975
What this trial is testing

Study of Skin Tumors in Tuberous Sclerosis

Who this might be right for
Tuberous Sclerosis
National Heart, Lung, and Blood Institute (NHLBI) 400
Not applicableUnknownNCT05168215
What this trial is testing

Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease.

Who this might be right for
SclerodermaDigital UlcerAutoimmune Diseases+2 more
Elpen Pharmaceutical Co. Inc. 300
Testing effectiveness (Phase 2)Study completedNCT02161406
What this trial is testing

Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Dinesh Khanna, MD, MS 88
Testing effectiveness (Phase 2)WithdrawnNCT05098145
What this trial is testing

A Safety and Efficacy Study of FCR001 in Adults With Rapidly Progressive Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
Talaris Therapeutics Inc.
Testing effectiveness (Phase 2)Ended earlyNCT04837131
What this trial is testing

Evaluate the Safety and Tolerability of Oral Ixazomib in Scleroderma-related Lung Disease Patients

Who this might be right for
Systemic SclerosisSclerodermaDiffuse Systemic Sclerosis+16 more
Michael M. Pham 4
Load More Results